News

Mayne Pharma treatment for chronic breathlessness approved by TGA

20 February 2019 | Mayne Pharma Group Limited (ASX: MYX) is pleased to announce that the Therapeutic Goods Administration (TGA) has approved KAPANOL® low dose sustained-release 10mg and 20mg morphine capsules for the treatment of chronic breathlessness in…

Nominations open for the Bionics Institute Award for Excellence in Medical Device Innovation

15 February 2019 | Nominations are now open for the Bionics Institute Award for Excellence in Medical Device Innovation. The 2019 Bionics Institute Award acknowledges an individual who, through their innovation, has made a significant impact on the…

Cartherics and panCELLa announce collaborative agreement to develop pluripotent cell lines for cell therapy

13 February 2019  Cartherics and panCELLa are pleased to announce their collaboration to research, develop and commercialise products for the treatment of cancer and other debilitating diseases using cell therapy. panCELLa will integrate their exclusive FailSafeTM technology into Cartherics’ proprietary…

Nucleus Network expands early phase trial capacity in Australia with acquisition of Q-Pharm

11 February 2019 Nucleus Network recently announced its acquisition of Q-Pharm, a 62-bed dedicated early-phase clinical trial facility based in the Herston health precinct in Brisbane. Q-Pharm was previously wholly owned by the QIMR Berghofer Medical Research Institute.…

4th Annual CEO Remuneration Report – Wexford Hayes

31 January 2019 This 4th annual CEO Remuneration report reviews the remuneration of the top 100 public companies listed on the Australian Securities Exchange for the Health Care & Biotechnology Sector. The report provides insight into remuneration in…

25-27 March 2020 – Eradicate Cancer ‘How well is immunotherapy winning?’

25-27 March 2020 Melbourne Convention and Exhibition Centre “Success Breeds Success” The field of immunotherapy against cancers is making unprecedented progress. The Eradicate Cancer Conference “Can advanced immunotherapy make it possible?” held in March 2018 was a resounding success.…

Job: Product Manager – Pharmaceutical

Pharmaceutical Product Manager to play a key role in the launch of new pharmaceuticals into the Australian market. Closing date: not noted

Job: Senior Scientist – MiniFAB

MiniFAB, a leading provider of product development and manufacturing services to the global medical diagnostic market, require a Senior Scientist to join the team on a full-time basis. No application closing date noted.

Sienna furthers its Global Expansion with Distributor for the Republic of Korea

22 January 2019 Highlights: Mirax Corporation appointed as exclusive distributor for Korea Important expansion of commercial opportunity in high-growth Asian IVD market Sienna Cancer Diagnostics Ltd a medical technology company developing and commercialising innovative cancer related tests, continues…

Super Charging The Immune System to Fight Cancer

22 January 2019 Innovative immunotherapies for cancer are a step closer to reality thanks to an agreement between Australia’s Cartherics Pty Ltd and Seoul-based ToolGen Inc. The agreement, signed in Melbourne on 21 January 2019, enables the companies…

Imagion Biosystems teams with Planet Innovation for MagSense™ instrument development

MELBOURNE — Imagion Biosystems Limited (ASX: IBX), a company dedicated to improving healthcare through the earlier detection of cancer, and Planet Innovation, a healthtech innovation and commercialization company, are pleased to announce that they have entered into a…

Victoria leads the way with NHMRC funding

13 December 2018  The announcement of the latest round of NHMRC funding yesterday has again highlighted the strength of Melbourne’s medical research community. Continuing the state’s unbroken record of receiving more than 40% of NHMRC competitive grant funding,…

Home

News & opinion

Member Directory

Events